Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
0.558
+0.004 (0.72%)
Jan 17, 2025, 4:00 PM EST - Market closed
Amarin Corporation Employees
Amarin Corporation had 275 employees as of December 31, 2023. The number of employees decreased by 90 or -24.66% compared to the previous year.
Employees
275
Change (1Y)
-90
Growth (1Y)
-24.66%
Revenue / Employee
$876,440
Profits / Employee
-$143,076
Market Cap
229.53M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
AMRN News
- 5 weeks ago - Amarin Receives National Reimbursement for VAZKEPA® in Italy - GlobeNewsWire
- 5 weeks ago - Amarin Appoints Peter Fishman Chief Financial Officer - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 2 months ago - Amarin Corporation plc (AMRN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting - GlobeNewsWire
- 5 months ago - Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress - GlobeNewsWire
- 6 months ago - Amarin Corporation plc (AMRN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire